GCCL develops Korea's first automatic clinical trial data sharing system

GCCL develops Korea's first automatic clinical trial data sharing system

Global Clinical Central Lab (GCCL), an affiliate of South Korean pharmaceutical firm Green Cross Corp., said on Monday it has jointly developed Kore...

KSOE to develop large-capacity fuel cells with Europe's research center

KSOE to develop large-capacity fuel cells with Europe's research center

Korea Shipbuilding & Offshore Engineering (KSOE), an intermediate holding company of HD Hyundai Co., has decided to develop fuel cells for mar...

Daewoong, Onchorus to undertake research on mRNA anticancer drugs

Daewoong, Onchorus to undertake research on mRNA anticancer drugs

Daewoong Pharmaceutical said on Thursday that it has signed a joint R&D and commercialization agreement with America's biopharmaceutical venture...

HLB confirms ophthalmic disease treatment in phase 3 clinical trials

HLB confirms ophthalmic disease treatment in phase 3 clinical trials

South Korea’s biomedicine startup HLB Therapeutics Co. said on Monday that its Neurotrophic Keratopathy (NK) treatment RGN-259 proved effectiv...

Daewoong Pharma, Neurolive to jointly develop new antidepressant drug

Daewoong Pharma, Neurolive to jointly develop new antidepressant drug

South Korea's drug company Daewoong Pharmaceutical said on Wednesday that it has signed an agreement with biopharmaceutical venture Neurorive to joi...

Korea auto output to increase slightly in 2023: research

Korea auto output to increase slightly in 2023: research

Domestic automobile output next year is forecast to increase 1.4% over this year to 3.7 million units.The Korea Automobile Manufacturers Association...

Medipost's Cartistem shows effects on patellar cartilage defect patients

Medipost's Cartistem shows effects on patellar cartilage defect patients

Medipost's knee osteoarthritis treatment Cartistem has been mentioned in a renowned international journal, showing that it is effective even in pati...

GI Cell wins approval for human cell management from Korean regulator

GI Cell wins approval for human cell management from Korean regulator

GI Cell, a South Korean developer of immune cell therapy products, received a human cell and others management license from South Korean regulatory,...

CJ applies to FDA for trials of immuno-anticancer drug candidate

CJ applies to FDA for trials of immuno-anticancer drug candidate

CJ Bioscience, an independent red bio (pharmaceutical and healthcare) subsidiary of CJ CheilJedang Corp., said on Monday it has submitted a phase 1 ...

85% of S.Korea's Gen MZ have contactless savings accounts

85% of S.Korea's Gen MZ have contactless savings accounts

A study finds 90% of South Korea's Generation MZ, a demographic comprising millennials and Generation Z members born between 1981 and 2010, use cont...

Celltrion applies for FDA approval for Remsima SC

Celltrion applies for FDA approval for Remsima SC

Celltrion Ltd. said on Friday it had applied the previous day for permission from the US Food and Drug Administration (FDA) for Remsima SC, an autoi...

GC Biopharma confirms safety of flu vaccine in phase 1 trial

GC Biopharma confirms safety of flu vaccine in phase 1 trial

South Korea's leading pharmaceutical company GC Biopharma Corp. said on Thursday that it has confirmed the safety and immunogenicity of the patch-ty...

SK Biopharm begins clinical trials of wearable device for detecting epilepsy

SK Biopharm begins clinical trials of wearable device for detecting epilepsy

SK Group's new drug development subsidiary SK Biopharmaceuticals Co. will begin clinical trials for a wearable device that can detect and predict ep...

SK Ecoplant earns AA grade for FTC's voluntary compliance program

SK Ecoplant earns AA grade for FTC's voluntary compliance program

South Korea's construction engineering company SK Ecoplant Co., Ltd. is accelerating its environmental, social, and governance (ESG) management effo...

S. Korea's SillaJen launches clinical trials in US for new anti-cancer drug

S. Korea's SillaJen launches clinical trials in US for new anti-cancer drug

South Korean biotech company Sillajen Inc. has started recruiting patients for Phase 1 clinical trials in the US for an anti-cancer drug from a Swis...

New drug developer Onconic Therapeutics raises $20 mn in Series B

New drug developer Onconic Therapeutics raises  $20 mn in Series B

South Korean drug developer Onconic Therapeutics, announced on Friday that it raised 26 billion won ($19.9 million) in Series B funding, with cumula...

LIG Nex1, KAIST, HHI sign MOU for unmanned marine system partnership

LIG Nex1, KAIST, HHI sign MOU for unmanned marine system partnership

South Korea's defense contractor LIG Nex1 Co. took part in the "2022 Yi Sun-sin Defense Industry Exhibition" held at the Jinhae Naval Academy on Wed...

South Korea needs to attract more foreign professionals: FKI

South Korea needs to attract more foreign professionals: FKI

In order to address the chronic shortage of industrial engineering manpower, a research report proposed that South Korea put more effort into attracti...

MDimune signs research agreement with Australian National University

MDimune signs research agreement with Australian National University

MDimune, a South Korean biotech company, said on Wednesday that it had signed an agreement with the Clear Vision Research (CVR) Lab, a research grou...

JW Pharmaceutical relocates US research center from Seattle to Boston

JW Pharmaceutical relocates US research center from Seattle to Boston

JW Pharmaceutical announced on Wednesday that it has relocated its US research center to Boston from San Diego. JW Theriac was first establishe...

KT adds partner to expand Vietnam digital healthcare biz

KT adds partner to expand Vietnam digital healthcare biz

KT Corp., a major South Korean telecom operator, has teamed up with another local company to expand its digital healthcare business in Vietnam furth...

Korea should open retail electricity market for renewables

Korea should open retail electricity market for renewables

South Korea on Oct. 26 officially launched the carbon neutrality commission based on laws for green growth, which took effect last March, amid the g...

Korean bio suffers as weak won lifts global clinical trial costs

Korean bio suffers as weak won lifts global clinical trial costs

South Korean biopharmaceutical firms are facing challenges in clinical trials overseas alongside the rising Korean won to the US dollar exchange rat...

Hansol Group, KAIST to launch new tech, AI research center

Hansol Group, KAIST to launch new tech, AI research center

South Korea’s Hansol Group and the Korea Advanced Institute of Science and Technology (KAIST) have agreed to establish a research center to de...

ETRI bolsters semiconductor technologies for use in aerospace defense

ETRI bolsters semiconductor technologies for use in aerospace defense

Daejeon-based Electronics and Telecommunications Research Institute (ETRI) is poised to further the development of semiconductor technologies for us...

KAIST, NYU to operate joint campus in New York City from 2023

KAIST, NYU to operate joint campus in New York City from 2023

Korea Advanced Institute of Science and Technology (KAIST), South Korea's most prestigious national research university, and New York University wil...

NCSOFT publishes three AI academic papers at INTERSPEECH 2022 

NCSOFT publishes three AI academic papers at INTERSPEECH 2022 

South Korea’s gaming giant NCSOFT Corp. will present three academic papers at INTERSPEECH 2022, the world’s largest and most comprehensi...

LG AI center joins forces with Parsons School for creative AI development 

LG AI center joins forces with Parsons School for creative AI development 

South Korea’s LG Corp. announced it signed an academic collaboration agreement with the New York City-based Parsons School of Design on Monday...

Cash-rich Nongshim pursues first-ever sizeable acquisition

Cash-rich Nongshim pursues first-ever sizeable acquisition

Nongshim Co., South Korea’s No. 1 instant noodle brand, is looking to buy a domestic food supplement maker for up to $50 million, which would ...

Lotte Group to donate $10.4 mn to KAIST to build R&D, design centers

Lotte Group to donate $10.4 mn to KAIST to build R&D, design centers

Lotte Corp. announced on Monday that it will donate 14 billion won ($10.4 million) to the prestigious Korea Advanced Institute of Science and Techno...

S.Korea’s extra budget approved; IBs lift economic forecast BTS’ Suga, MLB star Chan Ho Park to join Oakland Athletics as shareholders Celltrion secures $730 mn to buy biosimilar unit shares, pursue M&A Korean commercial act revision to drive reevaluation of equities: J.P. Morgan S.Korea to elevate science minister to deputy prime minister to lead in AI race